FutureChem Co.,Ltd (KOSDAQ:220100)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,500
-1,200 (-5.06%)
Mar 28, 2025, 3:30 PM KST
105.29%
Market Cap 497.18B
Revenue (ttm) 17.29B
Net Income (ttm) -9.42B
Shares Out 22.10M
EPS (ttm) -426.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 257,783
Average Volume 417,074
Open 23,650
Previous Close 23,700
Day's Range 22,500 - 23,900
52-Week Range 8,610 - 31,250
Beta 1.42
RSI 45.34
Earnings Date Mar 17, 2025

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of radiopharmaceuticals in South Korea. The company offers PDVUE, a positron emission tomography (PET) radiopharmaceutical diagnostic medicine for Parkinson’s disease; Alzavue, a radiopharmaceutical for Aalzheimer's disease; and [18F]FDG, a PET radiopharmaceutical for the treatment of cancer. Its products in pipeline include 18F-FC303 and 177Lu-FC705 for the treatment of prostate cancer; 18F-FMT for the treatment of brain tumor; 18F-FC505, for the treatment of athe... [Read more]

Sector Healthcare
Founded 1999
Employees 66
Stock Exchange KOSDAQ
Ticker Symbol 220100
Full Company Profile

Financial Performance

In 2024, FutureChem Co.,Ltd's revenue was 17.29 billion, an increase of 23.81% compared to the previous year's 13.97 billion. Losses were -9.42 billion, 40.4% more than in 2023.

Financial Statements

News

There is no news available yet.